StockNews.com started coverage on shares of Comstock (NYSE:LODE – Free Report) in a research note published on Tuesday. The brokerage issued a sell rating on the stock.
Comstock Price Performance
Shares of NYSE LODE opened at $0.28 on Tuesday. Comstock has a 52 week low of $0.28 and a 52 week high of $0.99. The stock has a market cap of $34.02 million, a price-to-earnings ratio of 3.78 and a beta of 2.01. The company’s 50-day moving average price is $0.37 and its 200 day moving average price is $0.44. The company has a current ratio of 1.56, a quick ratio of 1.56 and a debt-to-equity ratio of 0.07.
Comstock (NYSE:LODE – Get Free Report) last released its quarterly earnings results on Wednesday, February 28th. The company reported ($0.03) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.01. Comstock had a net margin of 718.51% and a negative return on equity of 4.04%. The company had revenue of $0.45 million for the quarter, compared to analysts’ expectations of $1.10 million. As a group, research analysts forecast that Comstock will post -0.15 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Comstock
About Comstock
Comstock Inc engages in the systemic decarbonization business in Nevada and internationally. It operates through Renewable Energy, Mining, and Strategic and Other Investments segments. It will develop technology for the deploying of extraction and refining facilities that convert wasted and unused biomass and other natural resources; and a demonstration system to extract black mass containing lithium, graphite, nickel, cobalt, manganese, copper, aluminum, and other metals from up to lithium-ion batteries.
Recommended Stories
- Five stocks we like better than Comstock
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- What is a Secondary Public Offering? What Investors Need to Know
- Hilton Demonstrates Asset Light is Right for Investors
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Comstock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Comstock and related companies with MarketBeat.com's FREE daily email newsletter.